Atea Pharmaceuticals Inc.

AVIR | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.64

+$0.21 (+3.87%)

At close: Sep 22, 2026, 4:00 PM ET

$5.64

$0 (0.00%)

After-hours: Sep 22, 2026, 4:54 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-158.35M	-168.39M	-135.96M	-115.91M	121.19M	-10.95M
Depreciation & Amortization	416K	416K	416K	260K	29K	19K
Stock-Based Compensation	20.72M	51.77M	49.43M	46.72M	39.62M	7.46M
Other Working Capital	8M	-7.68M	14.46M	-44.6M	-258.13M	306.51M
Other Non-Cash Items	-4.94M	-11.82M	33.11M	-5.47M	29.39M	n/a
Deferred Income Tax	-6.36M	n/a	-48.56M	n/a	-29.39M	n/a
Change in Working Capital	16.48M	-7.48M	16.16M	-46.59M	-247.85M	300.21M
Operating Cash Flow	-132.03M	-135.5M	-85.4M	-120.98M	-87.01M	296.73M
Capital Expenditures	n/a	n/a	n/a	-1.94M	-4K	-26K
Cash Acquisitions	n/a	n/a	n/a	453.47K	n/a	n/a
Purchase of Investments	-281.94M	-461.18M	-562.36M	-545.35M	n/a	n/a
Sales Maturities Of Investments	470.73M	517.28M	602.67M	91.89M	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-453.47K	n/a	n/a
Investing Cash Flow	188.79M	56.11M	40.3M	-455.41M	-4K	-26K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-25.52M	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-485K	n/a	n/a	140K	n/a	n/a
Financial Cash Flow	-25.75M	267K	257K	370K	1.47M	531.75M
Net Cash Flow	31.02M	-79.13M	-44.84M	-576.02M	-85.54M	828.46M
Free Cash Flow	-132.03M	-135.5M	-85.4M	-122.93M	-87.01M	296.71M
Adj. Free Cash Flow	-152.75M	-187.27M	-134.82M	-169.64M	-126.63M	289.25M
Maintenance CapEx	n/a	n/a	n/a	-1.94M	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	-4K	-26K
Owner Earnings	-132.03M	-135.5M	-85.4M	-122.93M	-87.01M	296.73M